Hypocitraturia despite potassium citrate tablet supplementation
- PMID: 17406150
- PMCID: PMC1781310
Hypocitraturia despite potassium citrate tablet supplementation
Abstract
Citrate supplementation is widely used in the prevention of recurrent nephrolithiasis with hypocitraturia. Potassium citrate is the most commonly used citrate agent for this indication. In patients with chronic diarrheal syndromes, the absorption of potassium citrate can be affected. We describe a patient who presented with recurrent nephrolithiasis and chronic diarrhea and was found to have severe hypocitraturia despite citrate supplementation with potassium citrate tablets, likely due to inadequate gastrointestinal absorption of citrate from the slow-release wax-matrix tablets.
References
-
- Simpson DP. Citrate excretion: a window on renal metabolism. Am J Physiol. 1983;244:F223–F234. - PubMed
-
- Nicar MJ, Skurla C, Sakhaee K, Pak CY. Low urinary citrate excretion in nephrolithiasis. Urology. 1983;21:8–14. - PubMed
-
- Pattaras JG, Moore RG. Citrate in the management of urolithiasis. J Endourol. 1999;13:687–692. - PubMed
-
- Menon M, Mahle CJ. Urinary citrate excretion in patients with renal calculi. J Urol. 1983;129:1158–1160. - PubMed
-
- Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol. 1993;7:207–211. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical